DC B22-0699 | 2017-2018 | 22nd Council
Status
Spectrum: Partisan Bill (Democrat 9-0)
Status: Introduced on February 20 2018 - 25% progression, died in chamber
Action: 2018-02-23 - Notice of Intent to Act on B22-0699 Published in the DC Register
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 20 2018 - 25% progression, died in chamber
Action: 2018-02-23 - Notice of Intent to Act on B22-0699 Published in the DC Register
Text: Latest bill text (Introduced) [PDF]
Summary
As introduced, this bill prohibits insurance companies from factoring the use of pre-exposure prophylaxis in decisions related to the issuance of disability, life, or long-term care insurance policies. Pre-exposure prohylaxis means daily oral antiretroviral medication with a fixed-dose combination of tenofovir disoproxil fumarate and emtricitabine.
Title
Pre-exposure Prophylaxis Insurance Discrimination Amendment Act Of 2018
Sponsors
| Cnc. Mary Cheh [D] | Cnc. Phil Mendelson [D] | Cnc. Charles Allen [D] | Cnc. Jack Evans [D] |
| Cnc. Brandon Todd [D] | Cnc. Anita Bonds [D] | Cnc. Brianne Nadeau [D] | Cnc. Robert White [D] |
| Cnc. David Grosso [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-02-23 | Council | Notice of Intent to Act on B22-0699 Published in the DC Register |
| 2018-02-20 | Council | Referred to Committee on Business and Economic Development |
| 2018-02-20 | Council | Introduced in Committee of the Whole |
Washington D.C. State Sources
| Type | Source |
|---|---|
| Summary | http://lims.dccouncil.gov/Legislation/B22-0699 |
| Text | http://lims.dccouncil.gov/Download/39731/B22-0699-Introduction.pdf |
